Firefly Neuroscience Announces Shareholder Update Call
![Firefly Neuroscience Announces Shareholder Update Call](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
Firefly Neuroscience Announces Shareholder Update Call
Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF) is an Artificial Intelligence (“AI”) technology company dedicated to developing innovative neuroscientific solutions aimed at improving brain health outcomes for patients dealing with mental illnesses and neurological disorders. Today, Firefly announced that management will host a shareholder update call to keep stakeholders informed about the company's latest developments and innovation strategies.
Event Details
The upcoming shareholder update call is designed to provide stakeholders with the latest updates from Firefly. Here are the details:
Important Information
Event: Firefly Neuroscience Shareholder Update
Date: To be announced
Time: 5:00 PM Eastern Time
About Firefly Neuroscience
Firefly is committed to transforming the traditional approaches to treating mental health issues through cutting-edge technology. The company’s FDA-510(k) cleared Brain Network Analytics (BNA) platform aims to revolutionize diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD.
Investment and Development
Over the past decade and a half, Firefly has invested approximately $60 million into the development of its BNA platform. This investment has allowed the company to build a comprehensive database of brain wave tests and secure important patent protections necessary for producing and deploying leading technology solutions in brain health.
Commercial Launch of BNA Platform
Firefly is in the process of launching its BNA platform commercially, targeting partnerships with pharmaceutical companies that are focused on drug research and clinical trials. Additionally, the platform is geared toward medical practitioners looking for new tools and solutions to enhance clinical usage in patient diagnostics.
Technical Overview of BNA
The BNA is a software as a medical solution (SAMS). It utilizes advanced artificial intelligence and machine learning techniques on Firefly’s proprietary database. This extensive database consists of standardized, high-definition, longitudinal electroencephalograms (EEGs) from over 17,000 patients representing twelve neurological and mental health disorders, as well as insights from clinically normal patient cohorts.
Enhancing Clinical Insights
The BNA platform, when used in conjunction with an FDA-cleared EEG system, equips clinicians with comprehensive insights into brain function and cognition. Such insights significantly enhance clinicians’ capabilities to accurately diagnose mental illnesses and cognitive disorders, while also determining the most appropriate therapies or drugs to optimize patient outcomes.
Contact Information for Investors
For any inquiries regarding investments in Firefly Neuroscience or to learn more about their innovative solutions, stakeholders are encouraged to reach out to the company’s investor relations team:
Investor Contact
KCSA Strategic Communications
Valter Pinto or Jack Perkins
Phone: (212) 896-1254
Email: Firefly@KCSA.com
Media Inquiries
For media relations or further insights about Firefly Neuroscience, please contact:
Media Contact
KCSA Strategic Communications
Raquel Cona, Vice President
Phone: (516) 779-2630
Email: Rcona@KCSA.com
Frequently Asked Questions
What is the purpose of the shareholder update call?
The call aims to provide shareholders with updates on Firefly Neuroscience’s advancements and corporate strategies regarding their innovative solutions.
What technologies does Firefly Neuroscience focus on?
Firefly focuses on developing artificial intelligence-driven solutions for improving brain health, particularly through its BNA platform.
How does the BNA platform benefit clinicians?
The BNA platform enhances clinicians’ abilities to diagnose mental health and cognitive disorders accurately and determine effective treatments.
Who can I contact for investor relations inquiries?
For investment inquiries, contact KCSA Strategic Communications at (212) 896-1254 or email Firefly@KCSA.com.
What disorders does the BNA platform address?
The BNA platform addresses a variety of conditions, including depression, ADHD, anxiety disorders, and more neurocognitive issues.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Northern 2 VCT PLC Director Dealings Update
- Northern Venture Announces Equity Allotment and Voting Rights
- Vaisala Corporation Announces Managers' Transaction Details
- Northern 2 VCT PLC Announces Share Allotment
- Northern 3 VCT PLC Announces Share Allotment and Voting Rights
- Swiss Properties Invest A/S Announces Share Transactions
- Bekaert Announces Liquidity Agreement Update
- INVL Baltic Real Estate Shareholders Meeting Resolutions
- Management Board Update at A/S Delfi
- PayPoint plc Announces Share Buyback Details